Diagnostics & Research stocks
28 Diagnostics & Research companies have a page on Investingly, worth $881.3B together. The largest is Thermo Fisher Scientific (TMO) at $245.5B.
The median company trades at 38.9 times earnings, keeps 10.7% of revenue as operating profit and grew revenue 11.0% over the last year.
Waters grew revenue fastest (+113%); IDEXX Laboratories has the widest operating margin (32%); 6 of them pay a dividend (median yield 0.6%).
Diagnostics & Research companies, largest first
| # | Company | Market cap | P/E | P/FCF | Revenue growth | Operating margin | ROE | Dividend yield |
|---|---|---|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific IncTMO | $245.5B | 36.3x | 39.0x | +10.5% | 17.6% | 13.2% | 0.27% |
| 2 | Danaher CorporationDHR | $151.8B | 41.6x | 28.9x | +5.5% | 20.4% | 7.6% | 0.64% |
| 3 | Natera IncNTRA | $57.6B | — | 527.9x | +37.7% | -10.7% | -10.6% | — |
| 4 | Agilent Technologies IncA | $47.8B | 37.2x | 41.4x | +8.1% | 22.2% | 19.6% | 0.60% |
| 5 | Waters CorporationWAT | $42.6B | 108.7x | 78.9x | +113.3% | 7.1% | 1.1% | — |
| 6 | IQVIA Holdings IncIQV | $42.3B | 31.5x | 20.7x | +8.4% | 13.2% | 22.3% | — |
| 7 | IDEXX Laboratories IncIDXX | $42.2B | 39.3x | 40.1x | +9.7% | 32.0% | 70.7% | — |
| 8 | Illumina IncILMN | $41.1B | 49.4x | 44.2x | +9.4% | 19.6% | 29.1% | — |
| 9 | Mettler-Toledo International IncMTD | $33.4B | 38.9x | 39.4x | +4.5% | — | 7062.4% | — |
| 10 | Laboratory Corporation of America HoldingsLH | $25.9B | 28.0x | 21.5x | +5.8% | 10.4% | 11.7% | 0.92% |
| 11 | Quest Diagnostics IncorporatedDGX | $25.0B | 25.0x | 18.4x | +10.2% | 14.1% | 14.1% | 1.5% |
| 12 | Guardant Health IncGH | $22.1B | — | — | +44.3% | -39.8% | — | — |
| 13 | Medpace Holdings IncMEDP | $17.3B | 38.2x | 25.4x | +17.2% | 21.0% | 113.3% | — |
| 14 | Revvity Inc.RVTY | $17.3B | 74.5x | 34.0x | +1.3% | 12.3% | 3.3% | 0.18% |
| 15 | ICON PLCICLR | $12.4B | 21.4x | 11.0x | +1.2% | 3.6% | 0.45% | — |
| 16 | Twist Bioscience CorpTWST | $9.8B | — | — | +23.2% | -33.6% | -30.7% | — |
| 17 | Qiagen NVQGEN | $9.8B | 23.4x | 21.6x | +5.7% | 22.3% | 11.2% | — |
| 18 | GRAIL, LLCGRAL | $6.6B | — | — | +25.7% | -338.4% | -15.4% | — |
| 19 | RadNet IncRDNT | $5.7B | — | 67.0x | +25.0% | 3.1% | -1.9% | — |
| 20 | Sotera Health CoSHC | $5.1B | 43.3x | 34.0x | +9.2% | — | 24.6% | — |
| 21 | BillionToOne, Inc. Class A Common StockBLLN | $4.3B | 172.7x | 273.0x | +64.4% | 10.9% | 7.0% | — |
| 22 | Veracyte IncVCYT | $4.3B | 49.5x | 33.7x | +15.5% | 18.8% | 8.2% | — |
| 23 | Adaptive Biotechnologies CorpADPT | $4.1B | — | — | +21.5% | -12.2% | -44.7% | — |
| 24 | CareDx IncCDNA | $3.2B | — | 89.9x | +52.2% | 23.6% | 26.1% | — |
| 25 | GeneDx Holdings Corp.WGS | $2.4B | — | 170.3x | +11.4% | -20.3% | -43.5% | — |
| 26 | Castle Biosciences IncCSTL | $1.1B | — | 38.8x | +20.1% | -9.0% | -4.1% | — |
| 27 | Biodesix IncBDSX | $255M | — | — | +34.2% | -20.0% | -303.6% | — |
| 28 | Burning Rock Biotech LtdBNR | $166M | — | — | +4.6% | -10.2% | -10.3% | — |
Medians use companies with a value for that measure; P/E only counts companies with positive earnings. Every company links to its page with the reverse DCF, insider buying and 13F holders.
Other Healthcare industries
Questions
What are the largest Diagnostics & Research stocks?
By market value: Thermo Fisher Scientific (TMO), Danaher (DHR), Natera (NTRA), Agilent Technologies (A), Waters (WAT).
What is the average P/E ratio of Diagnostics & Research stocks?
The median Diagnostics & Research company on Investingly trades at 38.9 times trailing earnings (companies with positive earnings only).
How many Diagnostics & Research stocks pay a dividend?
6 of 28, with a median yield of 0.6%.
Prices and ratios as of Oct 11, 2026. Statements from SEC filings. Information only, not investment advice.